Published in Circulation on September 15, 1995
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest (1996) 3.64
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest (2005) 2.44
Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A (1996) 1.92
Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology (2006) 1.80
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol (1996) 1.66
Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol (1997) 1.64
The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med (2008) 1.51
ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest (2001) 1.24
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet (2006) 1.18
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J Lipid Res (2008) 1.16
Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol (1996) 1.13
Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. Arch Med Sci (2010) 1.09
MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Physiol Rep (2014) 1.07
Matrix metalloproteases and PAR1 activation. Blood (2012) 1.05
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol (2011) 1.03
Monocytic cell type-specific transcriptional induction of collagenase. J Clin Invest (1996) 1.02
Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci (2011) 0.96
Collagenases and cracks in the plaque. J Clin Invest (2013) 0.96
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension (2010) 0.96
Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm (2013) 0.95
IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype. Am J Pathol (2011) 0.95
Inflammation in acute coronary syndromes. Heart (2002) 0.94
Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol (2002) 0.94
Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol Cell Biol (1999) 0.92
Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir Physiol Neurobiol (2010) 0.92
MR plaque imaging of the carotid artery. Neuroradiology (2010) 0.91
MRI in the early identification and classification of high-risk atherosclerotic carotid plaques. Imaging Med (2010) 0.89
Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: tissue microarray detection of collagen I, collagen III and elastin levels. Interact Cardiovasc Thorac Surg (2012) 0.89
Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression. J Biol Chem (2009) 0.86
Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels. Circ Cardiovasc Genet (2009) 0.85
Combined two-photon luminescence microscopy and OCT for macrophage detection in the hypercholesterolemic rabbit aorta using plasmonic gold nanorose. Lasers Surg Med (2012) 0.84
Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am J Pathol (1996) 0.84
Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis. J Biol Chem (2013) 0.84
Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. BMC Med Genet (2013) 0.80
How to best manage glycemia and non-glycemia during the time of acute myocardial infarction. Diabetes Technol Ther (2012) 0.80
Dual-wavelength multifrequency photothermal wave imaging combined with optical coherence tomography for macrophage and lipid detection in atherosclerotic plaques using gold nanoparticles. J Biomed Opt (2012) 0.80
Age-dependent increases in interstitial collagenase and MAP Kinase levels are exacerbated by superoxide dismutase deficiencies. Exp Gerontol (2009) 0.79
Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits. J Korean Med Sci (2004) 0.77
Resveratrol, wine, and atherosclerosis. Int J Angiol (2012) 0.77
Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction. Int J Angiol (2011) 0.76
The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke. Int J Mol Sci (2016) 0.75
[Valvular calcifications in a patient on hemodialysis in Morocco]. Pan Afr Med J (2016) 0.75
Matrix metalloproteinases in cerebral ischemia. J Clin Neurol (2006) 0.75
Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression. Free Radic Biol Med (2014) 0.75
Characterization of fracture behavior of human atherosclerotic fibrous caps using a miniature single edge notched tensile test. Acta Biomater (2016) 0.75
The immune system in atherosclerosis and in acute myocardial infarction. Heart Int (2006) 0.75
Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice. EMBO Mol Med (2016) 0.75
Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells. PLoS One (2017) 0.75
Matrix metalloproteinases in exercise and obesity. Vasc Health Risk Manag (2016) 0.75
Coronary Artery Plaque Imaging. Curr Atheroscler Rep (2017) 0.75
Academic dentistry--where is everybody? Br Dent J (2006) 6.70
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest (1983) 6.05
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
Osteopontin is expressed in human aortic valvular lesions. Circulation (1995) 4.16
Mechanisms of stenosis after arterial injury. Lab Invest (1983) 3.75
The Use of Soluble Starch Medium in the Preparation of Smooth "O" Salmonella Antigens. J Bacteriol (1946) 3.72
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol (1986) 3.50
Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (1977) 3.25
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest (1993) 2.89
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest (1990) 2.83
Concern about safety of carotid angioplasty. Stroke (1996) 2.73
Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 2.71
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol (1996) 2.60
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53
The use of postal reminders to reduce non-attendance at an orthodontic clinic: a randomised controlled trial. Br Dent J (2003) 2.52
Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res (1994) 2.49
Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr (2002) 2.49
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A (1998) 2.46
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem (2001) 2.40
Antigen chimaeras of poliovirus as potential new vaccines. Nature (1988) 2.38
The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol (1997) 2.29
Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res (1985) 2.28
Orthodontic treatment for prominent upper front teeth in children. Cochrane Database Syst Rev (2007) 2.27
The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem (1981) 2.26
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Quality control in orthodontics: risk/benefit considerations. Br Dent J (1991) 2.04
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res (1980) 2.00
Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation (1998) 2.00
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol (1986) 1.99
TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol (1996) 1.96
Matrilysin expression and function in airway epithelium. J Clin Invest (1998) 1.94
Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A (1996) 1.92
Autopsy findings in the acquired immune deficiency syndrome. JAMA (1984) 1.91
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother (2006) 1.91
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res (1988) 1.91
Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest (1986) 1.91
Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem (1983) 1.89
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol (1998) 1.87
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85
The use of occlusal indices: a European perspective. Am J Orthod Dentofacial Orthop (1995) 1.84
Temporal gene regulation during HIV-1 infection of human CD4+ T cells. Genome Res (2001) 1.83
Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis (1999) 1.81
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol (1986) 1.80
The development of the PAR Index (Peer Assessment Rating): reliability and validity. Eur J Orthod (1992) 1.78
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol (1989) 1.77
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest (1983) 1.75
Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A (1989) 1.74
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest (1995) 1.69
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol (1990) 1.67
Ruptured abdominal aortic aneurysm: the Harborview experience. J Vasc Surg (1991) 1.66
Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int (1998) 1.66
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res (1995) 1.64
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63
Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A (1986) 1.63
Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem (1997) 1.62
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest (1985) 1.61
Construction of the endoplasmic reticulum. J Cell Biol (1989) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet (2000) 1.58
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem (1992) 1.57
Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest (1993) 1.56
Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis (1996) 1.55
Chemical species in fly ash from coal-burning power plants. Science (1980) 1.54
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem (1996) 1.53
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation (1998) 1.52
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation (2000) 1.51
A survey of the opinions of orthodontic specialist trainees in the U.K. Br J Orthod (1997) 1.51
The sonopartogram: a novel method for recording progress of labor by ultrasound. Ultrasound Obstet Gynecol (2014) 1.50
Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int (1998) 1.50
Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int (2000) 1.49
Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr (1998) 1.49
Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest (1985) 1.49
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res (1993) 1.49
Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis (1990) 1.49
The collagen substrate specificity of human neutrophil collagenase. J Biol Chem (1987) 1.49
Regulation of the mammalian collagenases. Coll Relat Res (1984) 1.49
Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem (1983) 1.49
Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney. Kidney Int (1999) 1.49
Effect of physical training on total and visceral fat in obese children. Med Sci Sports Exerc (1999) 1.48
Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg (1987) 1.47